Christopher R Morrison

Address:

1903 Victoria Ave SW, Seattle, WA 98126

VIN:

1G1ZT58F87F179098

Make:

CHEVROLET

Model:

MALIBU

Year:

2007

US Patent:

6571375, May 27, 2003

Filed:

May 8, 2000

Appl. No.:

09/566682

Inventors:

Prakash Narain - San Carlos CA
Rajeev K. Ranjan - Santa Clara CA
Christopher R. Morrison - Sunnyvale CA
John M. Beardslee - Menlo Park CA

Assignee:

Real Intent, Inc. - Santa Clara CA

International Classification:

G06F 1750

US Classification:

716 5, 716 4

Abstract:

A method and apparatus are provided that facilitate analysis of the intended flow of logical signals between key points in a design. According to one aspect of the present invention, multiple design verification checks associated with a hardware design are linked by determining dependency reationships among the multiple design verification checks. Each of the design verification checks represent a condition that must hold true in order for the hardware design to operate in accordance with an intended flow of logical signals in the hardware design.

US Patent:

6651228, Nov 18, 2003

Filed:

May 8, 2000

Appl. No.:

09/566684

Inventors:

Prakash Narain - San Carlos CA
Rajiv Kumar - Santa Clara CA
John M. Beardslee - Menlo Park CA
Rajeev K. Ranjan - Santa Clara CA
Christopher R. Morrison - Sunnyvale CA

Assignee:

Real Intent, Inc. - Santa Clara CA

International Classification:

G06F 1750

US Classification:

716 5, 716 4

Abstract:

A method and apparatus are provided that facilitate analysis of the intended flow of logical signals between key points in a design. According to one aspect of the present invention, hardware design defects can be detected using a novel Intent-Driven Verification process. First, a representation of a hardware design and information regarding the intended flow of logical signals among variables in the representation are received. Then, the existence of potential errors in the hardware design may be inferred based upon the information regarding the intended flow of logical signals by (1) translating the information regarding the intended flow of logical signals into a comprehensive set of checks that must hold true in order for the hardware design to operate in accordance with the intended flow of logical signals, and (2) determining if any of the checks can be violated during operation of circuitry represented by the hardware design.

US Patent:

6704912, Mar 9, 2004

Filed:

Jan 24, 2001

Appl. No.:

09/770068

Inventors:

Prakash Narain - San Carlos CA
Rajeev K. Ranjan - Santa Clara CA
Christopher R. Morrison - Sunnyvale CA
John M. Beardslee - Menlo Park CA

Assignee:

Real Intent, Inc. - Santa Clara CA

International Classification:

G06F 1750

US Classification:

716 4, 716 5, 716 6

Abstract:

A method and apparatus for characterizing information about design attributes is described. The characterization process may begin with determining the dependency among the attributes within a hardware design. Once the dependency is determined, the most relevant information about the hardware design attribute may be highlighted. A user can then focus their attention on the highlighted aspects of the design attribute to draw conclusions about the hardware design as a whole.

US Patent:

6713650, Mar 30, 2004

Filed:

Dec 5, 2001

Appl. No.:

10/011016

Inventors:

Prabha N. Ibrahim - Mountain View CA 94040
Robert Jiang - Mountain View CA 94041
Christopher Morrison - Sunnyvale CA 94087
Kevin Shenk - Palo Alto CA 94306
Jeff A. Zablocki - Mountain View CA 94040
Richard Lawn - San Francisco CA 94116

International Classification:

C07C23305

US Classification:

564188, 564 26, 564 90, 564 91, 564 92, 564155, 514585, 514604, 514616, 514623

Abstract:

The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.

US Patent:

6839884, Jan 4, 2005

Filed:

Jan 18, 2001

Appl. No.:

09/766189

Inventors:

Prakash Narain - San Carlos CA, US
Rajeev K. Ranjan - Santa Clara CA, US
Christopher Morrison - Sunnyvale CA, US
John M. Beardslee - Menlo Park CA, US
Rajiv Kumar - Santa Clara CA, US

Assignee:

Real Intent, Inc. - Santa Clara CA

International Classification:

G06F 1750
G06F 945

US Classification:

716 5, 716 4

Abstract:

A method and apparatus are described that facilitate validation of a hardware design having multiple hierarchical levels. In one embodiment, a representation of the hardware design is received, and the hardware design is validated by performing validation processing on a plurality of sub-problems. Each of the plurality of sub-problems covers a computationally feasible size of the hardware design at a corresponding hierarchical level. In another embodiment, validation of a hardware design includes making use of validation processing previously performed with respect to one or more modules included in the hardware design based on the hierarchical relationship between these modules and other modules included in the hardware design.

US Patent:

6900219, May 31, 2005

Filed:

Apr 4, 2003

Appl. No.:

10/407875

Inventors:

Prabha Ibrahim - Mountain View CA, US
Michael Campbell - Durham NC, US
Robert Jiang - Cupertino CA, US
Christopher Morrison - Sunnyvale CA, US
Kevin Shenk - Palo Alto CA, US
William Shirley - La Jolla CA, US
Jeff Zablocki - Mountain View CA, US
Dmitry Koltun - Millbrae CA, US
Reina Natero - Menlo Park CA, US

Assignee:

CV Therapeutics, Inc. - Palo Alto CA

International Classification:

A61K031/517
A61K031/425
A61K031/415

US Classification:

5142661, 5142662, 514365, 514367, 514406

Abstract:

The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.

US Patent:

6995285, Feb 7, 2006

Filed:

Jun 4, 2002

Appl. No.:

10/161923

Inventors:

Prabha N. Ibrahim - Mountain View CA, US
Robert Jiang - Cupertino CA, US
Christopher Morrison - Richmond TX, US
Kevin Shenk - Palo Alto CA, US
Jeff A. Zablocki - Mountain View CA, US

Assignee:

CV Therapeutics, Inc. - Palo Alto CA

International Classification:

C07C 233/06
A61K 31/165

US Classification:

564191, 564 26, 564 90, 564 91, 564 92, 564155, 564158, 564188, 514580, 514588, 514613, 514623, 514624

Abstract:

The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.

US Patent:

7144871, Dec 5, 2006

Filed:

Feb 19, 2003

Appl. No.:

10/370679

Inventors:

Prabha Ibrahim - Mountain View CA, US
Elfatih Elzein - Fremont CA, US
Kevin Shenk - Palo Alto CA, US
Robert Jiang - Mountain View CA, US
Jeff Zablocki - Mountain View CA, US
Xiaofen Li - Palo Alto CA, US
Christopher Morrison - Sunnyvale CA, US
Thao Perry - San Jose CA, US
Dengming Xiao - Longmont CO, US

Assignee:

CV Therapeutics, Inc. - Palo Alto CA

International Classification:

A61K 31/70
C07H 19/167

US Classification:

514 46, 536 2723

Abstract:

Disclosed are novel compounds that are partial and full Aadenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, myocardial infarction and hyperlipidemia.